CareMax
CMAX

$6.39

9.93%

Market Cap: 24.3M

About: CareMax Inc is a technology-enabled care platform providing value-based care and chronic disease management to seniors. It operates various owned medical centers that offer a comprehensive suite of healthcare and social services and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States.

Employees: 1,450

Healthcare Nursing & Personal Care Facilities

0

Funds holding %

of 6,702 funds

–

Analysts bullish %

–

News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

2.26% less ownership

Funds ownership: 59.98% [Q4 2023] → 57.72% (-2.26%) [Q1 2024]

29% less funds holding

Funds holding: 59 [Q4 2023] → 42 (-17) [Q1 2024]

69% less capital invested

Capital invested by funds: $33.6M [Q4 2023] → $10.5M (-$23.1M) [Q1 2024]

71% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 24

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 35

See Fund Rankings

Research analyst outlook

1 Wall Street Analyst provided 1 year price forecasts over the past 6 months

Low target

$6.40

0%

upside

Avg. target

$6.40

0%

upside

High target

$6.40

0%

upside

1 analyst rating

0 positive

0%

1 neutral

100%

0 negative

0%

UBS

A.J. Rice

0%upside

$6.4

Neutral

Maintained

1 Apr 2024

See Analyst Rankings

Financial journalist opinion

CareMax Reports First Quarter 2024 Results

MIAMI--(BUSINESS WIRE)--CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a leading technology-enabled value-based care delivery system, today announced financial results for the first quarter ended March 31, 2024. “During the first quarter of 2024, we believe we began to see benefits from our fourth quarter clinical efforts which became fully implemented toward the end of last year,” said Carlos de Solo, Chief Executive Officer. “While absolute levels of utilization remained el.

CareMax Reports First Quarter 2024 Results

3 Stocks That Are Actually Worth Shorting for Endless Gains

There's an old Wall Street adage that says “the market can stay irrational longer than you can stay solvent.” We saw that play out time and again with certain beaten-down stocks.

3 Stocks That Are Actually Worth Shorting for Endless Gains

Zacks Investment Research

New Strong Sell Stocks for April 1st

BMRC, CPRI and CMAX have been added to the Zacks Rank #5 (Strong Sell) List on April 1, 2023.

New Strong Sell Stocks for April 1st

Zacks Investment Research

New Strong Sell Stocks for March 28th

ASLE, CPRI and CMAX have been added to the Zacks Rank #5 (Strong Sell) List on March 28, 2023.

New Strong Sell Stocks for March 28th

Zacks Investment Research

New Strong Sell Stocks for March 20th

CMAX, LNZA and HSON have been added to the Zacks Rank #5 (Strong Sell) List on March 20, 2024.

New Strong Sell Stocks for March 20th

CareMax, Inc. (CMAX) Q4 2023 Earnings Call Transcript

CareMax, Inc. (CMAX) Q4 2023 Earnings Call Transcript

CareMax, Inc. (CMAX) Q4 2023 Earnings Call Transcript

CareMax Reports Fourth Quarter and Full Year 2023 Results

MIAMI--(BUSINESS WIRE)--CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a leading technology-enabled value-based care delivery system, today announced financial results for the fourth quarter and full year ended December 31, 2023. “In the fourth quarter, we began taking major steps with the goal of solidifying the long-term viability of our business,” said Carlos de Solo, Chief Executive Officer. “We have made difficult but necessary decisions to de-emphasize certain longer du.

CareMax Reports Fourth Quarter and Full Year 2023 Results

CMAX ALERT: Levi & Korsinsky, LLP Commences an Investigation of CareMax, Inc. (CMAX) f/k/a Deerfield Healthcare Technology Acquisitions Corp. (DFHT)

NEW YORK , March 12, 2024 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:1 To: All Persons or Entities who purchased CareMax, Inc. ("(CMAX) " or the "Company") ( NASDAQ: CMAX ) stock prior to May 25, 2021 Levi & Korsinsky, LLP has commenced an investigation into potential breaches of fiduciary duty by the CMAX board of directors. To learn more about the action and your rights, go to: https://zlk.com/mna2/caremax-inc-lawsuit-submission-form or contact Joseph E.

CMAX ALERT: Levi & Korsinsky, LLP Commences an Investigation of CareMax, Inc. (CMAX) f/k/a Deerfield Healthcare Technology Acquisitions Corp. (DFHT)

CareMax Announces 1-for-30 Reverse Stock Split

MIAMI--(BUSINESS WIRE)--CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a leading technology-enabled value-based care delivery system, today announced that the Company's Board of Directors (the “Board”) has approved a 1-for-30 reverse stock split (the “Reverse Stock Split”) of its Class A common stock, par value $0.0001 per share (the “Class A Common Stock”), that is expected to become effective on Wednesday, January 31, 2024 at 11:59 p.m. Eastern Time (the “Effective Time”).

CareMax Announces 1-for-30 Reverse Stock Split

See News Rankings